Arden Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,814
| Closed | -$337K | – | 282 |
|
|
2021
Q4 | $337K | Sell |
3,814
-49
| -1% | -$4.33K | 0.06% | 244 |
|
|
2021
Q3 | $299K | Sell |
3,863
-160
| -4% | -$12.4K | 0.05% | 248 |
|
|
2021
Q2 | $335K | Sell |
4,023
-322
| -7% | -$26.8K | 0.06% | 239 |
|
|
2021
Q1 | $328K | Sell |
4,345
-745
| -15% | -$56.2K | 0.06% | 249 |
|
|
2020
Q4 | $446K | Sell |
5,090
-320
| -6% | -$28K | 0.07% | 209 |
|
|
2020
Q3 | $412K | Sell |
5,410
-1,545
| -22% | -$118K | 0.07% | 211 |
|
|
2020
Q2 | $857K | Sell |
6,955
-1,669
| -19% | -$206K | 0.16% | 126 |
|
|
2020
Q1 | $729K | Buy |
8,624
+1,798
| +26% | +$152K | 0.15% | 128 |
|
|
2019
Q4 | $577K | Sell |
6,826
-454
| -6% | -$38.4K | 0.09% | 203 |
|
|
2019
Q3 | $491K | Buy |
7,280
+309
| +4% | +$20.8K | 0.08% | 218 |
|
|
2019
Q2 | $597K | Buy |
6,971
+663
| +11% | +$56.8K | 0.1% | 194 |
|
|
2019
Q1 | $561K | Buy |
6,308
+35
| +0.6% | +$3.11K | 0.09% | 213 |
|
|
2018
Q4 | $534K | Buy |
6,273
+587
| +10% | +$50K | 0.1% | 194 |
|
|
2018
Q3 | $551K | Buy |
5,686
+79
| +1% | +$7.66K | 0.09% | 207 |
|
|
2018
Q2 | $528K | Buy |
+5,607
| New | +$528K | 0.08% | 205 |
|